chr12-122867324-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_024667.3(VPS37B):c.650G>A(p.Gly217Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000126 in 1,590,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024667.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS37B | NM_024667.3 | c.650G>A | p.Gly217Glu | missense_variant | 4/4 | ENST00000267202.7 | NP_078943.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS37B | ENST00000267202.7 | c.650G>A | p.Gly217Glu | missense_variant | 4/4 | 1 | NM_024667.3 | ENSP00000267202.2 | ||
VPS37B | ENST00000535765.5 | c.644G>A | p.Gly215Glu | missense_variant | 4/4 | 3 | ENSP00000446075.1 |
Frequencies
GnomAD3 genomes AF: 0.00000674 AC: 1AN: 148460Hom.: 0 Cov.: 29
GnomAD4 exome AF: 6.94e-7 AC: 1AN: 1441784Hom.: 0 Cov.: 41 AF XY: 0.00000140 AC XY: 1AN XY: 715922
GnomAD4 genome AF: 0.00000674 AC: 1AN: 148460Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 72354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.650G>A (p.G217E) alteration is located in exon 4 (coding exon 4) of the VPS37B gene. This alteration results from a G to A substitution at nucleotide position 650, causing the glycine (G) at amino acid position 217 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at